Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study

Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study

Abstract Background Antiviral treatment for chronic hepatitis B (CHB) is largely unavailable in sub-Saharan Africa; hence, little is known about the prognosis after initiating treatment in African CHB patients. In this study we aimed to assess predictors of mortality in one of the largest CHB cohort...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hailemichael Desalegn, Hanna Aberra, Nega Berhe, Girmay Medhin, Bitsatab Mekasha, Svein Gunnar Gundersen, Asgeir Johannessen
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	BMC 2019-05-01
Sraith:	BMC Gastroenterology
Ábhair:	Hepatitis B Antiviral therapy Survival Resource-limited settings Epidemiology
Rochtain ar líne:	http://link.springer.com/article/10.1186/s12876-019-0993-1

Míreanna comhchosúla

Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia
de réir: Hailemichael Desalegn, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa
de réir: Hanna Aberra, et al.
Foilsithe / Cruthaithe: (2017-06-01)

Mother-to-Child Transmission of Hepatitis B Virus in Ethiopia
de réir: Asgeir Johannessen, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Five-year results of a treatment program for chronic hepatitis B in Ethiopia
de réir: Hailemichael Desalegn, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Low awareness and common misconceptions about schistosomiasis in endemic lowland areas in Western Ethiopia: a mixed-methods study
de réir: Alemayehu Assefa, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Current status of Schistosoma mansoni infection among previously treated rural communities in the Abbey and Didessa Valleys, Western Ethiopia: Implications for sustainable control.
de réir: Alemayehu Assefa, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings.
de réir: Kathrine Stene-Johansen, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Unexplained chronic liver disease in Ethiopia: a cross-sectional study
de réir: Stian Magnus Staurung Orlien, et al.
Foilsithe / Cruthaithe: (2018-02-01)

High Seroprevalence of Autoantibodies Typical of Autoimmune Liver Disease in Eastern Ethiopia: Is Chewing of Khat (Catha edulis) a Triggering Factor?
de réir: Stian Magnus Staurung Orlien, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Clinico-epidemiological study of Schistosomiasis mansoni in Waja-Timuga, District of Alamata, northern Ethiopia
de réir: Nigus Abebe, et al.
Foilsithe / Cruthaithe: (2014-04-01)

Preoperative Antiviral Therapy and Long-Term Outcomes for Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Liver Resection: A Multicenter Analysis
de réir: Dai MG, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Prevalence and intensity of Schistosoma mansoni infection, and contributing factors in Alamata district of Tigray Region, Northern Ethiopia.
de réir: Gessessew Bugssa, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Factors associated with treatment initiation delay among new adult pulmonary tuberculosis patients in Tigray, Northern Ethiopia.
de réir: Kiros Tedla, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
de réir: Jung Hee Kim, et al.
Foilsithe / Cruthaithe: (2016-11-01)

Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
de réir: Adugna Endale Woldegiorgis, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Survival of Extremely Preterm Neonates in a Resource-limited Setting
de réir: Iretiola Fajolu, et al.
Foilsithe / Cruthaithe: (2019-09-01)

ETIOTROPIC THERAPY OF VIRAL HEPATITIS
de réir: S. B. Chuelov, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
de réir: Ming‐Lun Yeh, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Advanced therapy for hepatitis C /
de réir: McCaughan, Geoffrey W., et al.
Foilsithe / Cruthaithe: (2012)

Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis
de réir: Angela Devine, et al.
Foilsithe / Cruthaithe: (2017-08-01)

New antiviral agents and new treatments on the horizon for the management of viral hepatitis
de réir: M. Sönmezoğlu
Foilsithe / Cruthaithe: (2011-12-01)

Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy
de réir: Shousheng Liu, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Knowledge and practice on prevention of diabetes mellitus among Diabetes mellitus family members, in suburban cities in Ethiopia
de réir: Mistire Wolde, et al.
Foilsithe / Cruthaithe: (2017-11-01)

Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients
de réir: Isabel Campos-Varela, et al.
Foilsithe / Cruthaithe: (2014-03-01)

Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study
de réir: Mehdi Kashani, et al.
Foilsithe / Cruthaithe: (2024-10-01)

HCV RNA in peripheral blood mononuclear cells (PBMCs) as a predictor of the response to antiviral therapy in chronic hepatitis C
de réir: Abdel Fatah Fahmy Hanno, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs
de réir: Amira Isaac, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence
de réir: Ciro Celsa, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
de réir: Lilian Yan Liang, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naÏve Patients Infected with Genotype 1b Hepatitis C Virus
de réir: Ye Wang, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Magnitude and genotype of hepatitis delta virus among chronic hepatitis B carriers with a spectrum of liver diseases in Ethiopia
de réir: Yayehyirad Tassachew, et al.
Foilsithe / Cruthaithe: (2023-01-01)

The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia
de réir: Lee AS, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Plant-derived antivirals against hepatitis c virus infection
de réir: Ana Carolina Gomes Jardim, et al.
Foilsithe / Cruthaithe: (2018-02-01)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
de réir: Hendrik Luxenburger, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
de réir: Che C. Colpitts, et al.
Foilsithe / Cruthaithe: (2016-08-01)

Last Stop Before Exit – Hepatitis C Assembly and Release as Antiviral Drug Targets
de réir: Birke Andrea Tews, et al.
Foilsithe / Cruthaithe: (2010-08-01)

Viral hepatitis E: Clinical manifestations, treatment, and prevention
de réir: Qiumin Luo, et al.
Foilsithe / Cruthaithe: (2024-03-01)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
de réir: S. V. Zhavoronok, et al.
Foilsithe / Cruthaithe: (2018-10-01)

Prevention of mother to child transmission of hepatitis B virus infection in Nigeria: A call to action
de réir: Eke CB, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Nuevos progresos en el enfrentamiento a la hepatitis C
de réir: Alfredo Enrique Arredondo Bruce, et al.